GoAI
Get started
BioNexus Gene Lab Corp. logo

BioNexus Gene Lab Corp.

BGLC

NASDAQIndustrialsIndustrial - Distribution

Open in GoAI

Previous close

$1.59

+$0.0035 · +0.22%

Aug 21, 4:00 PM ET

BGLC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

18

Strong Down

Sentiment

54

Mixed

Risk resilience

18

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Industry
Industrial - Distribution
Sector
Industrials
Headquarters
MY
CEO
Su-Leng Tan
Listed since
Jan 8, 2021
Employees
19

Market position

Day range

Current $1.59

52-week range

Current $1.59

Open
$1.70
Previous close
$1.5865
Volume
985
0.01× average
Average volume
102.59K
Average daily volume
Market cap
3.84M USD
Beta
2.19
Market reference 1
50-day average
$1.7889
-11.12% below average
200-day average
$2.6981
-41.07% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.13M USD
P/E (TTM)
-1.26×
P/B (TTM)
0.49×
P/S (TTM)
1.23×
EV / EBITDA
-1.83×
Earnings yield
-40.70%
Free cash flow yield
-25.57%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
11.64%
Operating margin
-82.78%
Net margin
-82.36%
Return on equity
-34.64%
Return on assets
-32.26%
Return on invested capital
-35.93%

Financial health

Debt / equity
0.03×
Current ratio
10.46×
Altman Z-score
1.22
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends22%-1%-25%-48%Gross margin, FY2021: 16.42%Gross margin, FY2022: 11.52%Gross margin, FY2023: 13.61%Gross margin, FY2024: 13.56%Gross margin, FY2025: 14.62%Operating margin, FY2021: 7.90%Operating margin, FY2022: -2.66%Operating margin, FY2023: -26.54%Operating margin, FY2024: -16.55%Operating margin, FY2025: -42.54%Net margin, FY2021: 5.62%Net margin, FY2022: -3.26%Net margin, FY2023: -26.91%Net margin, FY2024: -16.81%Net margin, FY2025: -40.20%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 16.42%. Gross margin FY2022 11.52%. Gross margin FY2023 13.61%. Gross margin FY2024 13.56%. Gross margin FY2025 14.62%. Operating margin FY2021 7.90%. Operating margin FY2022 -2.66%. Operating margin FY2023 -26.54%. Operating margin FY2024 -16.55%. Operating margin FY2025 -42.54%. Net margin FY2021 5.62%. Net margin FY2022 -3.26%. Net margin FY2023 -26.91%. Net margin FY2024 -16.81%. Net margin FY2025 -40.20%.

Income trends

Revenue

7.42M USD-21.93%

Operating income

−3.16M USD-100.70%

Net income

−2.98M USD-86.73%
Income trends across reported periods15.01M USD8.41M USD1.8M USD−4.81M USDRevenue, FY2021: 13.36M USDRevenue, FY2022: 10.93M USDRevenue, FY2023: 9.77M USDRevenue, FY2024: 9.51M USDRevenue, FY2025: 7.42M USDOperating income, FY2021: 1.06M USDOperating income, FY2022: −291.18K USDOperating income, FY2023: −2.59M USDOperating income, FY2024: −1.57M USDOperating income, FY2025: −3.16M USDNet income, FY2021: 751.57K USDNet income, FY2022: −355.97K USDNet income, FY2023: −2.63M USDNet income, FY2024: −1.6M USDNet income, FY2025: −2.98M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 13.36M USD. Revenue FY2022 10.93M USD. Revenue FY2023 9.77M USD. Revenue FY2024 9.51M USD. Revenue FY2025 7.42M USD. Operating income FY2021 1.06M USD. Operating income FY2022 −291.18K USD. Operating income FY2023 −2.59M USD. Operating income FY2024 −1.57M USD. Operating income FY2025 −3.16M USD. Net income FY2021 751.57K USD. Net income FY2022 −355.97K USD. Net income FY2023 −2.63M USD. Net income FY2024 −1.6M USD. Net income FY2025 −2.98M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue7.42M USD9.51M USD9.77M USD10.93M USD13.36M USD
Cost of goods sold6.34M USD8.22M USD8.44M USD9.67M USD11.17M USD
Gross profit1.09M USD1.29M USD1.33M USD1.26M USD2.19M USD
Research and development50.67K USD47.51K USD54.98K USD——
Selling, general, and administrative4.07M USD4M USD3.04M USD1.73M USD1.2M USD
Operating expenses4.24M USD2.86M USD3.92M USD1.55M USD1.14M USD
Interest income83.89K USD147.64K USD———
Interest expense19.54K USD21.15K USD13.93K USD12.48K USD12.97K USD
Depreciation and amortization168.31K USD153.14K USD108.42K USD105.42K USD108.22K USD
Operating income−3.16M USD−1.57M USD−2.59M USD−291.18K USD1.06M USD
Net income−2.98M USD−1.6M USD−2.63M USD−355.97K USD751.57K USD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.12

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-0.03-0.21-0.39-0.57Q4 '24Q2 '25Q2 '25Q3 '25Q4 '25Q2 '26Q2 '26Q3 '26
Q4 2024, reported Nov 15, 2024: actual -0.2, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 15, 2025: actual -0.194, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual -0.03, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 18, 2025: actual -0.34, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual -0.39, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 14, 2026: actual -0.53, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual -0.23, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual -0.12, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates2.84M1.9M959.27K19.42KQ4 '24Q2 '25Q2 '25Q3 '25Q4 '25Q2 '26Q2 '26Q3 '26
Q4 2024, reported Nov 15, 2024: actual 2.63M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 15, 2025: actual 2.52M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 2.14M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 18, 2025: actual 2.26M USD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 2.54M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 14, 2026: actual 483.76K USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 22.84K USD, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 76.16K USD, estimate —, surprise —, Comparison unavailable.

BGLC news

Corporate actions

Corporate action history

Stock split

Effective Apr 7, 2025

1:10

Stock split

Effective Jul 20, 2023

1:12

BGLC peers

Space Exploration Technologies Corp. logo

SPCX

Space Exploration Technologies Corp.

$136.97

+2.22%

CSX Corporation logo

CSX

CSX Corporation

$51.59

+1.22%

Cintas Corporation logo

CTAS

Cintas Corporation

$203.79

+0.13%

PACCAR Inc logo

PCAR

PACCAR Inc

$131.03

+1.62%

Honeywell International Inc. logo

HON

Honeywell International Inc.

$215.9

-1.11%

Fastenal Company logo

FAST

Fastenal Company

$51.26

+1.18%

Continue in GoAI

Research BGLC

research.disclaimer